We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Fear eats the soul

6 June 2007 By Robert Cyran

Investors in the UK drug maker have panicked over the possible recall of diabetes drug Avandia wiping £9bn off its market value. US Congressional hearings today on the drug may fuel more overreaction. That would make Glaxo s already cheap stock a veritable bargain.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)